| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 6138 | 2020 |
| Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the … AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ... Clinical infectious diseases 63 (5), e61-e111, 2016 | 4199 | 2016 |
| Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 2609 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1929 | 2021 |
| ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19-final report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... N Engl J Med 383 (19), 1813-1826, 2020 | 961 | 2020 |
| Anthrax infection DA Sweeney, CW Hicks, X Cui, Y Li, PQ Eichacker American journal of respiratory and critical care medicine 184 (12), 1333-1341, 2011 | 242 | 2011 |
| How to use biomarkers of infection or sepsis at the bedside: guide to clinicians P Póvoa, L Coelho, F Dal-Pizzol, R Ferrer, A Huttner, A Conway Morris, ... Intensive care medicine 49 (2), 142-153, 2023 | 164 | 2023 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 160 | 2021 |
| Infectious Diseases Society of America position paper: recommended revisions to the national severe sepsis and septic shock early management bundle (SEP-1) sepsis quality measure C Rhee, K Chiotos, SE Cosgrove, EL Heil, SS Kadri, AC Kalil, DN Gilbert, ... Clinical Infectious Diseases 72 (4), 541-552, 2021 | 160 | 2021 |
| An overview of anthrax infection including the recently identified form of disease in injection drug users CW Hicks, DA Sweeney, X Cui, Y Li, PQ Eichacker Intensive care medicine 38, 1092-1104, 2012 | 149 | 2012 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 107 | 2022 |
| The microbiome of the critically ill patient K Akrami, DA Sweeney Current opinion in critical care 24 (1), 49-54, 2018 | 71 | 2018 |
| ACTT-2 Study Group Members AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J …, 2021 | 58 | 2021 |
| Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines DA Sweeney, X Cui, SB Solomon, DA Vitberg, TS Migone, D Scher, ... Journal of Infectious Diseases 202 (12), 1885-1896, 2010 | 52 | 2010 |
| Once is not enough: clinical trials in sepsis DA Sweeney, RL Danner, PQ Eichacker, C Natanson Intensive care medicine 34 (11), 1955-1960, 2008 | 52 | 2008 |
| SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment C Marotz, P Belda-Ferre, F Ali, P Das, S Huang, K Cantrell, L Jiang, ... Microbiome 9 (1), 132, 2021 | 48 | 2021 |
| A ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature DA Sweeney, MT Caserta, DN Korones, A Casadevall, DL Goldman The Pediatric infectious disease journal 22 (12), 1089-1093, 2003 | 44 | 2003 |
| Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock CW Hicks, DA Sweeney, RL Danner, PQ Eichacker, AF Suffredini, J Feng, ... Critical care medicine 40 (1), 199-207, 2012 | 39 | 2012 |
| The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock CW Hicks, X Cui, DA Sweeney, Y Li, A Barochia, PQ Eichacker Toxins 3 (9), 1185-1202, 2011 | 32 | 2011 |
| Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia? DA Sweeney, AC Kalil Clinical Microbiology and Infection 25 (10), 1195-1199, 2019 | 28 | 2019 |
